India to Brazil: Actinomycin Export Trade Route
India has recorded 324 verified shipments of Actinomycin exported to Brazil, representing a combined trade value of $245.8K USD. This corridor is served by 18 active Indian exporters, with an average shipment value of $759 USD. The leading Indian exporter is IKRIS PHARMA NETWORK PRIVATE LIMITED, which accounts for 44% of total export value with 103 shipments worth $108.1K USD. On the buying side, TO THE ORDER OF, is the largest importer in Brazil with $66.7K USD in purchases. The top 3 suppliers — IKRIS PHARMA NETWORK PRIVATE LIMITED, VAMA LIFECARE PRIVATE LIMITED, GNH INDIA PHARMACEUTICALS LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Actinomycin corridor is one of India's established pharmaceutical export routes, with 324 shipments documented worth a combined $245.8K USD. The route is dominated by IKRIS PHARMA NETWORK PRIVATE LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 18 active suppliers, the average shipment value stands at $759 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 38 days port-to-port. The route has recorded an annual growth rate of 18.74%, placing it at rank #2 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Brazil include TO THE ORDER OF,, TO THE ORDER OF, TO THE ORDER and 107 others. TO THE ORDER OF, is the single largest importer with 59 shipments valued at $66.7K USD.
